207 related articles for article (PubMed ID: 36826778)
1. CircRTN1 stimulates HMGB1 to regulate the malignant progression of papillary thyroid cancer by sponging miR-101-3p.
Zheng M; Xu L; Wei C; Guan W
Hormones (Athens); 2023 Jun; 22(2):281-293. PubMed ID: 36826778
[TBL] [Abstract][Full Text] [Related]
2. Circ_0002111 modulates the growth process of papillary thyroid carcinoma cells by targeting the miR-363-3p/HMGB1 axis.
Zhang Z; Mo Y; Wu L; Wang X; Liao G; Tan W; Li D
Anticancer Drugs; 2022 Oct; 33(9):923-934. PubMed ID: 36136992
[TBL] [Abstract][Full Text] [Related]
3. circ_0067934 promotes the progression of papillary thyroid carcinoma cells through miR-1301-3p/HMGB1 axis.
Dong LP; Chen LY; Bai B; Qi XF; Liu JN; Qin S
Neoplasma; 2022 Jan; 69(1):1-15. PubMed ID: 34704451
[TBL] [Abstract][Full Text] [Related]
4. Circular RNA circ_0062389 modulates papillary thyroid carcinoma progression via the miR-1179/high mobility group box 1 axis.
Wang Y; Zong H; Zhou H
Bioengineered; 2021 Dec; 12(1):1484-1494. PubMed ID: 33926347
[TBL] [Abstract][Full Text] [Related]
5. CircRTN1 acts as a miR-431-5p sponge to promote thyroid cancer progression by upregulating TGFA.
Gao Y; Wang Y; Xu L; Xie X; Zhu L; Wang F
Hormones (Athens); 2022 Dec; 21(4):611-623. PubMed ID: 35804263
[TBL] [Abstract][Full Text] [Related]
6. Circular RNA circ_0008274 enhances the malignant progression of papillary thyroid carcinoma via modulating solute carrier family 7 member 11 by sponging miR-154-3p.
Ma J; Kan Z
Endocr J; 2021 May; 68(5):543-552. PubMed ID: 33473055
[TBL] [Abstract][Full Text] [Related]
7. Circ_0059354 aggravates the progression of papillary thyroid carcinoma by elevating ARFGEF1 through sponging miR-766-3p.
Li Z; Xu J; Guan H; Lai J; Yang X; Ma J
J Endocrinol Invest; 2022 Apr; 45(4):825-836. PubMed ID: 34854069
[TBL] [Abstract][Full Text] [Related]
8. circRNA mannosidase alpha class 1A member 2 contributes to the proliferation and motility of papillary thyroid cancer cells through upregulating metadherin via absorbing microRNA-449a.
Feng Y; Yang X; Wang Y; Chi N; Yu J; Fu X
Anticancer Drugs; 2023 Jan; 34(1):44-56. PubMed ID: 36066401
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-130a-3p impedes the progression of papillary thyroid carcinoma through downregulation of KPNB1 by targeting PSME3.
Wang Y; Xu J; Zhu X; Kuang H
Endocrine; 2023 Oct; 82(1):96-107. PubMed ID: 37166548
[TBL] [Abstract][Full Text] [Related]
10. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
Wang D; Zheng Y
Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
[TBL] [Abstract][Full Text] [Related]
11. Circ_0079558 promotes papillary thyroid cancer progression by binding to miR-26b-5p to activate MET/AKT signaling.
Zheng H; Fu Q; Ma K; Shi S; Fu Y
Endocr J; 2021 Nov; 68(11):1247-1266. PubMed ID: 34565758
[TBL] [Abstract][Full Text] [Related]
12. CircRNA NRIP1 promotes papillary thyroid carcinoma progression by sponging mir-195-5p and modulating the P38 MAPK and JAK/STAT pathways.
Li C; Zhu L; Fu L; Han M; Li Y; Meng Z; Qiu X
Diagn Pathol; 2021 Oct; 16(1):93. PubMed ID: 34689819
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of circPUM1 impedes cell growth, metastasis and glycolysis of papillary thyroid cancer via enhancing MAPK1 expression by serving as the sponge of miR-21-5p.
Li Y; Qin J; He Z; Cui G; Zhang K; Wu B
Genes Genomics; 2021 Feb; 43(2):141-150. PubMed ID: 33481227
[TBL] [Abstract][Full Text] [Related]
14. microRNA-124-3p inhibits tumourigenesis by targeting mitogen-activated protein kinase 4 in papillary thyroid carcinoma.
Sun Y; Zhang L; Zhang S
Cell Biochem Funct; 2020 Dec; 38(8):1017-1024. PubMed ID: 32495394
[TBL] [Abstract][Full Text] [Related]
15. MiR-548c-3p suppressed the progression of papillary thyroid carcinoma via inhibition of the HIF1α-mediated VEGF signaling pathway.
Du Y; Zhu J; Chu BF; Yang YP; Zhang SL
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6570-6578. PubMed ID: 31378898
[TBL] [Abstract][Full Text] [Related]
16. Silencing circRNA protein kinase C iota (circ-PRKCI) suppresses cell progression and glycolysis of human papillary thyroid cancer through circ-PRKCI/miR-335/E2F3 ceRNA axis.
Liu Y; Chen G; Wang B; Wu H; Zhang Y; Ye H
Endocr J; 2021 Jun; 68(6):713-727. PubMed ID: 33716239
[TBL] [Abstract][Full Text] [Related]
17. Circular RNA Pvt1 oncogene (CircPVT1) promotes the progression of papillary thyroid carcinoma by activating the Wnt/β-catenin signaling pathway and modulating the ratio of microRNA-195 (miR-195) to vascular endothelial growth factor A (VEGFA) expression.
Zeng L; Yuan S; Zhou P; Gong J; Kong X; Wu M
Bioengineered; 2021 Dec; 12(2):11795-11810. PubMed ID: 34927541
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA DUXAP8 promotes the cell proliferation, migration, and invasion of papillary thyroid carcinoma via miR-223-3p mediated regulation of CXCR4.
Liu Y; Zhang H; Wang H; Du J; Dong P; Liu M; Lin Y
Bioengineered; 2021 Dec; 12(1):496-506. PubMed ID: 33522355
[TBL] [Abstract][Full Text] [Related]
19. CircPI4KA Overexpression Enhances Carcinogenesis and Glycolysis Metabolism in Papillary Thyroid Carcinoma by Causing the miR-1287-5p-Mediated NRP2 Expression Elevation.
Sun H; Xu F; You D
Horm Metab Res; 2023 Oct; 55(10):701-710. PubMed ID: 37813099
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-3653-3p inhibited papillary thyroid carcinoma progression by regulating CRIPTO-1.
Bai X; Xu Y; Liu Y
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):272-276. PubMed ID: 38279419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
